Insider Cluster (1 insider) ·Filed Mar 19, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $281K total
Actionable Insight • Neutral

The activity is consistent with routine option exercise and minimal selling; not a signal of distress or strong conviction. Monitor for additional selling in coming days.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
RVMD ▲ +61.20% at T+60d
NEUTRAL call ✓ call won +61.20% · α vs SPY +46.86% · entry $99.29 → $160.06
Entry anchored
Mar 18, 03:59 PM ET
via exchange tick
T+1d
-3.54%
call -3.54% · α -1.79%
$95.78
settled 7mo ago
T+5d
-6.12%
call -6.12% · α -3.91%
$93.21
settled 6mo ago
T+20d
+49.69%
call +49.69% · α +42.07%
$148.63
settled 6mo ago
T+60d
+61.20%
call +61.20% · α +46.86%
$160.06
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Anthony Mancini, an insider at Revolution Medicines, exercised options for 74,900 shares and sold 1,800 shares on the open market for $167,801. The majority of the transaction value comes from non-cash derivative exercises, with only a small portion representing actual open-market selling.

Key Financial Metrics

Direction
selling
Total Value
$167.8K
Insiders
1

Key Facts

  • Anthony Mancini exercised options for 74,900 shares in two tranches of 37,450 shares each, one at $0 and one at $33.62 per share, resulting in a total cost of $1,259,069.
  • Mancini sold 1,800 shares on the open market for $167,801 at an average price of $93.223.
  • The total open-market sale represents approximately 0.0009% of Revolution Medicines' $18.7B market cap, well below the 0.1% threshold for materiality.

Financial Impact

$167,801 in open-market sales and $1.26M in derivative exercises (non-cash)

insider ownershippotential dilution

Risk Factors

  • Potential for minor dilution from newly exercised shares, though not material given company size.
  • Perception risk if more insiders follow with similar transactions.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-RVMD-1774569874022
26 reports for RVMD
Performance horizon
100% Hit rate 12 of 12 directional calls best @ T+60▲ +31.56%Apr 21, 2026
Filters
Rows
Reports for RVMD — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
144
NEUTRAL ★ 2/10
$195.92 $190.74▼ −2.64%▼ −5.21%$206.64 (+5.47%)
Sep 15, 2026
16d ago
144
NEUTRAL ★ 4/10
$195.92 $190.74▼ −2.64%▼ −5.21%$206.64 (+5.47%)
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$204.86 $190.95▼ −6.79%▼ −7.61%$206.64 (+0.87%)
Sep 14, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$204.86 $192.86▼ −5.86%▼ −7.98%$206.64 (+0.87%)
Aug 26, 2026
5w ago
8-K
BULLISH ★ 8/10
$215.44 $209.23▼ −2.88%▼ −2.76%$206.64 (−4.08%)
Aug 26, 2026
5w ago
Press Release
BULLISH ★ 8/10
$215.44 $209.23▼ −2.88%▼ −2.76%$206.64 (−4.08%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$211.38 $209.87▼ −0.71%▼ −0.18%$206.64 (−2.24%)
Jul 2, 2026
13w ago
Press Release
BULLISH ★ 7/10
$189.24 $191.13▲ +1.00%▲ +0.07%$206.64 (+9.19%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$187.51 $190.46▲ +1.57%▲ +1.31%$206.64 (+10.20%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$165.81 $192.62▲ +16.17%▲ +16.62%$206.64 (+24.62%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 27, 2026